Century Therapeutics, Inc. 8-K

What Happened Century Therapeutics, Inc. (NASDAQ: IPSC) announced its financial results for the year ended December 31, 2025 by filing a Form 8‑K on March 12, 2026. The company furnished a press release reporting its results (Exhibit 99.1) and an updated investor presentation (Exhibit 99.2), both incorporated by reference into the 8‑K. Under Regulation FD disclosure, the company stated the updated presentation will be used in meetings with investors going forward.

Key Details

• Filing date: March 12, 2026 (Form 8‑K Items 2.02 and 7.01).
• Period covered: financial results for the year ended December 31, 2025.
• Exhibits furnished: 99.1 — Press Release (financial results); 99.2 — Updated Investor Presentation.
• Company ticker: IPSC (Century Therapeutics, Inc.).

Why It Matters This 8‑K provides retail investors with Century Therapeutics’ official year‑end financial disclosure and the company’s current investor presentation, which together contain the most recent financial metrics and messaging the company will use with analysts and investors. Reviewing the press release and presentation is the primary way for shareholders to see the firm’s reported earnings performance, cash position and near‑term priorities as of year‑end 2025.